<?xml version="1.0" encoding="UTF-8"?>
<ref id="B60-viruses-12-00518">
 <label>60.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Venereo-Sanchez</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Simoneau</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lanthier</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Chahal</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Bourget</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Ansorge</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gilbert</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Henry</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Kamen</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line</article-title>
  <source>Vaccine</source>
  <year>2017</year>
  <volume>35</volume>
  <fpage>4220</fpage>
  <lpage>4228</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2017.06.024</pub-id>
  <pub-id pub-id-type="pmid">28648546</pub-id>
 </element-citation>
</ref>
